Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Dovobet Foam approved in Japan for psoriasis

Jan. 13, 2021

Cara opens phase II trial of oral difelikefalin for notalgia paresthetica pruritus

Jan. 11, 2021

New phase II trial evaluates SCD-044 for moderate to severe plaque psoriasis

Jan. 5, 2021

New CTP synthase 1 inhibitors described by Step Pharma

Dec. 29, 2020

New acetyl-CoA carboxylase inhibitors discovered at Almirall

Dec. 29, 2020

Topline data from pivotal phase II/III VALO study of Qtorin rapamycin in pachyonychia congenita

Dec. 24, 2020

FDA approves Klisyri for actinic keratosis on the face or scalp

Dec. 15, 2020

First patient dosed in phase II BLUEPRINT study of BLU-5937

Dec. 15, 2020

Hoth receives Australian clearance for phase Ib trial of BioLexa for atopic dermatitis

Dec. 11, 2020

AbbVie reports phase IIIb head-to-head data on upadacitinib in atopic dermatitis

Dec. 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...